Alex Philippidis

31March: Will Trump's planned tariffs return biopharma manufacturing to the U.S.? Which companies did @Jefferies say were most and least exposed if these tariffs take effect? Also, updates on $ATNA, $SAVA, $EQ, & $MURA in my latest StockWatch for @GENbio: https://t.co/UF1nirWC5c

31March: How have #biotech industry groups, an analyst, some research leaders and others addressed the surprising departure of Peter Marks, MD, from the FDA? Colleague and editor @KevinADavies and I summed up the responses for @GENbio: https://t.co/pcheX46LDd

SundayBest (Divine Liturgy of St. Basil the Great): Remember, Lord, those who are in mines, in exile, in harsh labor, and those in every kind of affliction, necessity, or distress; those who entreat your loving kindness; those who love us and those who hate us... https://t.co/wyvmLqdKRH

27March: It had to happen someday, his voice being stilled by age, but why now when his gift of song is so needed these days? https://t.co/GAf0pFAyDy

26March: How does @bmsnews explain its "Predict First" approach to applying #artificial_intelligence in drug discovery? Read insights from two $BMY executives in my latest Q&A for @GENbio: https://t.co/Aka0lnTdvm

24March: Just updated StockWatch this morning with an item on the Chapter 11 filing of @23andMe last night. Former CEO @annewoj23 has announced plans to bid for the company when it heads to bankruptcy court auction. More in @GENbio: https://t.co/Q9KVJ0zBUW

24March: Why have analysts remained bullish on @Sarepta after it disclosed the death of a DMD patient treated with its #GeneTherapy Elevidys? Read about $SRPT plus updates on $ELEV and $WINT in my latest StockWatch for @GENbio: https://t.co/Q9KVJ0A9Ku

23March: Which instrument companies are among "The Best of NGS" and worth watching in 2025? Check out my latest A-List for @GENbio: https://t.co/fzvBZwWf6B

SundayBest (Hymn of the Church & Kontakion Tone 4): To you, the invincible commander in chief we attribute victory, and sing praises of thanksgiving, O Theotokos. Keep us all unassailable and deliver us from all the dangers that beset us that we may sing: Hail, O bride unwedded. https://t.co/upUxFxz853

20-21March: How have @arbortx and @scribetx been pivoting from tools to develop editing therapies to clinical trials of those treatments? Hear from the CEOs of both companies in my latest for @GENbio: https://t.co/B46PuWoONo

20March: Happy to share my latest appearance on "Behind the Headlines," where I shared insights on biopharma news and trends with co-panelists @NeilJamesHunter, @jmsadowska, and @CMBS6, ably moderated by Chris Spivey of @MJHLifeSciences: https://t.co/0AStxWTfNE

RT @MatthewRhoa: @AlexWestchester @Sarepta @GENbio CMV is very common in boys and known to impact the liver. Surely an active CMV infectio…

18-19March: What has @Sarepta $SRPT said about the risk of liver injury in its label for Elevidys, the #GeneTherapy at the center of a young patient's sudden death, and in a recent presentation of data from 156 patients at #MDA 2025? My latest for @GENbio: https://t.co/urlHqz1TmS

17March: Why did @bmsnews investors react so coolly to its deal to acquire @2seventybio for $286M? Read about $BMY and $TSVT, plus updates on $APDN, $MGTX, $MLYS, & $STRO in my latest StockWatch for @GENbio: https://t.co/RZHM3Ht7VO

RT @GENbio: StockWatch: @AlexWestchester Reports on Noteworthy Market Movement Will @Bristol_Myers–@2seventybio Deal Prove a Win-Win?@APDN…

SundayBest (Divine Liturgy of St. Basil the Great): Look upon us, O God, and consider our worship; and accept it as You accepted the gifts of Abel, the sacrifices of Noah, the burnt offerings of Abraham, the priestly offices of Moses and Aaron, and the peace offerings of Samuel. https://t.co/uw01J6WAPY